Basal Cell Carcinoma (BCC) is the most common form of skin cancer, accounting for approximately 80% of all skin cancer cases. It arises from the basal cells in the deepest layer of the epidermis. BCC typically appears as a pearly or waxy bump, a flat flesh-colored or brown scar-like lesion, or a bleeding or scabbing sore that heals and returns. BCC grows slowly and rarely metastasizes (spreads to other parts of the body), but if left untreated, it can cause significant local tissue destruction, especially on the face, ears, and neck. Risk factors include fair skin, chronic sun exposure, intermittent intense sun exposure, and a history of blistering sunburns.

Squamous Cell Carcinoma (SCC) is the second most common skin cancer, making up about 20% of cases. It develops from the squamous cells in the middle and outer layers of the skin. SCC often appears as a firm red nodule, a flat sore with a scaly crust, or a rough, scaly patch on the lip or skin. Unlike BCC, SCC has a higher potential to metastasize, especially when located on the lips, ears, or in immunocompromised individuals. Cumulative lifetime sun exposure is the primary risk factor, and SCC is particularly common in organ transplant recipients due to immunosuppression. Early treatment is highly effective.

• Origin: BCC arises from basal cells; SCC from squamous cells.
• Prevalence: BCC is about 4x more common than SCC.
• Growth Pattern: BCC grows slowly and is locally invasive; SCC can grow faster and has metastatic potential.
• Key Triggers: BCC is linked to intermittent intense sun exposure and blistering sunburns; SCC is more strongly associated with cumulative lifelong UV exposure.
• Immunosuppression Impact: SCC risk is dramatically elevated in immunosuppressed patients (up to 65–250x higher); BCC risk is also increased but to a lesser extent.
• Metastasis Rate: BCC metastasizes in < 0.1% of cases; SCC metastasizes in 2–5% of cases overall, higher for high-risk locations.

Diagnosis begins with a thorough skin examination by a dermatologist, often using a dermatoscope for magnified visualization. If a suspicious lesion is identified, a skin biopsy is performed — a small sample is removed and examined under a microscope by a pathologist. This is the gold standard for diagnosis. The biopsy determines the type of skin cancer, its depth, and other characteristics that guide treatment. Regular self-exams using the ABCDE rule (Asymmetry, Border irregularity, Color variation, Diameter >6mm, Evolution/changes) can help detect potential issues early.

Treatment depends on the type, size, location, and depth of the cancer:

• Mohs Micrographic Surgery: The gold standard for high-risk BCC and SCC; offers the highest cure rate (up to 99%) while sparing healthy tissue.
• Standard Excision: Surgical removal with a margin of healthy skin.
• Curettage & Electrodesiccation: Scraping away the tumor followed by electric current to destroy remaining cells; suitable for small, low-risk lesions.
• Cryotherapy: Freezing the lesion with liquid nitrogen; used for superficial lesions.
• Topical Chemotherapy: Creams like 5-fluorouracil or imiquimod for superficial cancers.
• Radiation Therapy: For patients who cannot undergo surgery.
• Targeted Therapy/Immunotherapy: For advanced or metastatic cases.

Effective prevention strategies include:

• Use broad-spectrum sunscreen SPF 30+ daily, even on cloudy days; reapply every 2 hours outdoors.
• Wear protective clothing, wide-brimmed hats, and UV-blocking sunglasses.
• Avoid outdoor activities during peak UV hours (10 AM – 4 PM).
• Never use indoor tanning beds — they are classified as Group 1 carcinogens by the WHO.
• Perform monthly self-skin exams and have an annual professional skin check.
• Be especially vigilant if you have risk factors such as fair skin, family history, or a history of sunburns.
• Protect children from sunburns — early-life UV damage significantly increases lifetime risk.

The American Academy of Dermatology recommends:

• General population: A baseline skin exam in adulthood, with follow-up as recommended by your doctor.
• Higher-risk individuals: Annual full-body skin exams. High-risk factors include fair skin, family history of skin cancer, personal history of skin cancer or precancerous lesions, extensive sun exposure, or immunosuppression.
• Previous skin cancer patients: Every 3–6 months for the first 2–3 years, then annually or as directed by the dermatologist.
• Organ transplant recipients: At least annually, often more frequently due to dramatically elevated SCC risk.

This calculator is built on established epidemiological risk factors identified in peer-reviewed medical literature. It provides an educational estimate of relative risk based on population-level data. However, it cannot account for all individual variables (such as specific genetic mutations, precise UV dosage, or nuanced medical history). The tool is designed to raise awareness and encourage proactive skin health management — it is not a substitute for a clinical evaluation by a qualified healthcare provider. A dermatologist can provide a personalized risk assessment using clinical examination, dermatoscopy, and detailed medical history.

The ABCDE rule helps identify potential melanomas, but is also useful for spotting atypical lesions that warrant evaluation:

• A — Asymmetry: One half of the mole doesn't match the other.
• B — Border: Irregular, ragged, notched, or blurred edges.
• C — Color: Varied shades of brown, black, tan, red, white, or blue.
• D — Diameter: Larger than 6mm (about the size of a pencil eraser), though some melanomas can be smaller.
• E — Evolving: Any change in size, shape, color, or symptoms such as itching, bleeding, or crusting.

For BCC and SCC specifically, also look for: new growths, non-healing sores, pearly bumps, scaly patches, or any lesion that bleeds easily.

Yes. The World Health Organization's International Agency for Research on Cancer (IARC) classifies UV-emitting tanning devices as Group 1 carcinogens — the same category as asbestos, tobacco, and plutonium. Studies show that indoor tanning before age 35 increases the risk of:

• Basal Cell Carcinoma by 29–40%
• Squamous Cell Carcinoma by 58–67%
• Melanoma by 59–75%

There is no such thing as a "safe tan." A tan is actually a sign of DNA damage to skin cells. The use of tanning beds is responsible for over 400,000 cases of skin cancer each year in the United States alone.